Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comparative transcriptomic analysis of glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus
Christopher A. Smith, Ryan Patterson-Cross, Orla Woodward, et al.
Appetite (2022) Vol. 174, pp. 106022-106022
Open Access | Times Cited: 22

Showing 22 citing articles:

Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
Rola Hammoud, Daniel J. Drucker
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 4, pp. 201-216
Closed Access | Times Cited: 130
Glucose-dependent insulinotropic polypeptide (GIP)
Timo D. Müller, Alice E. Adriaenssens, Bo Ahrén, et al.
Molecular Metabolism (2025) Vol. 95, pp. 102118-102118
Open Access | Times Cited: 2
Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
Yolanda Diz-Chaves, Zainab Mastoor, Carlos Spuch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9583-9583
Open Access | Times Cited: 41
Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding
Alice E. Adriaenssens, Johannes Broichhagen, Anne de Bray, et al.
JCI Insight (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 30
The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease
Christine R. Andreasen, Andreas Andersen, Tina Vilsbøll
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1846-1858
Open Access | Times Cited: 27
Brain access of incretins and incretin receptor agonists to their central targets relevant for appetite suppression and weight loss
Sophie Buller, Clémence Blouet
AJP Endocrinology and Metabolism (2024) Vol. 326, Iss. 4, pp. E472-E480
Open Access | Times Cited: 10
GLP-1 programs the neurovascular landscape
Bandy Chen, Xiaofei Yu, Claudia Horvath-Diano, et al.
Cell Metabolism (2024) Vol. 36, Iss. 10, pp. 2173-2189
Closed Access | Times Cited: 10
Regulation of energy metabolism through central GIPR signaling
Arkadiusz Liśkiewicz, Timo D. Müller
Peptides (2024) Vol. 176, pp. 171198-171198
Open Access | Times Cited: 5
Obesity pharmacotherapy: incretin action in the central nervous system
Geke Aline Boer, Debbie L. Hay, Alexander Tups
Trends in Pharmacological Sciences (2022) Vol. 44, Iss. 1, pp. 50-63
Closed Access | Times Cited: 22
The Multiple Roles of Pericytes in Vascular Formation and Microglial Functions in the Brain
Yuki Hattori
Life (2022) Vol. 12, Iss. 11, pp. 1835-1835
Open Access | Times Cited: 19
Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain
Yolanda Diz-Chaves, Zainab Maastor, Carlos Spuch, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 8, pp. 1671-1677
Open Access | Times Cited: 11
GLP-1 receptor agonist-based and cardiovascular risk: a review of mechanisms
Neerav Mullur, Arianne Morissette, Nadya M. Morrow, et al.
Journal of Endocrinology (2024) Vol. 263, Iss. 1
Open Access | Times Cited: 4
Tirzepatide reduces body weight by increasing fat utilization via the central nervous system‐adipose tissue axis in male mice
Ailin Zhang, Qinhui Liu, Yimin Xiong, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
The role of GIPR in food intake control
Paula-Peace James-Okoro, Jo E. Lewis, Fiona M. Gribble, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Incretin-based therapeutics for the treatment of neurodegenerative diseases
Anika Vear, Michael T. Heneka, Christoffer Clemmensen
Nature Metabolism (2025)
Closed Access
Unravelling the GIPR agonist versus antagonist paradox
Alice E. Adriaenssens
Nature Metabolism (2025)
Closed Access
The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives
Marjan Gharagozloo, Danny Galleguillos, Larissa Jank, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 1229-1240
Closed Access | Times Cited: 9
Incretin hormones and pharmacomimetics rapidly inhibit AgRP neuron activity to suppress appetite
Hayley E. McMorrow, Carolyn M. Lorch, Nikolas W. Hayes, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease?
Óscar Moreno, Rebeca Reyes‐García, Inés Modrego Pardo, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 3
Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges
Chencheng Xie, Naim Alkhouri, Mohamed A. Elfeki
World Journal of Hepatology (2024) Vol. 16, Iss. 5, pp. 731-750
Open Access | Times Cited: 3
Glucagon-Like Peptide-1 Receptor Agonists as Potential Myelination-Inducible and Anti-Demyelinating Remedies
Kazunori Sango, Shizuka Takaku, Masami Tsukamoto, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 14
The GLP-1 analogue, exendin-4, improves bone material properties and strength through a central relay in ovariectomized mice
Morgane Mermet, Jessica Denom, A. Mieczkowska, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
An integrated single-cell transcriptome landscape of postnatal mouse hypothalamus
Muhammad Junaid, Han Kyoung Choe, Kunio Kondoh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top